Pliant Therapeutics, Inc.(PLRX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

PLRX Pliant Therapeutics, Inc.

交易中 07-18 12:24:22 EDT

12.43

-0.43

-3.34%

最高13.47	最低12.29	成交量16.85万
今开12.75	昨收12.86	日振幅9.18%
总市值7.50亿	流通市值5.75亿	总股本6,033万
成交额210.54万	换手率0.36%	流通股本4,626万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"PLRX","market":"US","secType":"STK","nameCN":"Pliant Therapeutics, Inc.","latestPrice":12.43,"timestamp":1721319846632,"preClose":12.86,"halted":0,"volume":168470,"delay":0,"floatShares":46258867,"shares":60325832,"eps":-2.857627,"marketStatus":"交易中","marketStatusCode":2,"change":-0.43,"latestTime":"07-18 12:24:22 EDT","open":12.75,"high":13.47,"low":12.29,"amount":2105449.7817200003,"amplitude":0.091757,"askPrice":12.45,"askSize":610,"bidPrice":12.43,"bidSize":161,"shortable":3,"etf":0,"ttmEps":-2.857627,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1721332800000},"adr":0,"listingDate":1591156800000,"adjPreClose":12.86,"preHourTrading":{"tag":"盘前","latestPrice":12.86,"preClose":12.86,"latestTime":"09:29 EDT","volume":118,"amount":1516.4799500000001,"timestamp":1721309373066},"postHourTrading":{"tag":"盘后","latestPrice":12.86,"preClose":12.86,"latestTime":"16:20 EDT","volume":29838,"amount":383716.68,"timestamp":1721247602698},"volumeRatio":0.454788,"impliedVol":1.0689,"impliedVolPercentile":0.9603},"requestUrl":"/m/hq/s/PLRX/wiki","defaultTab":"wiki","newsList":[{"id":"2452166805","title":"Pliant Therapeutics, Inc.盘中异动 大幅下挫5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452166805","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452166805?lang=zh_cn&edition=full","pubTime":"2024-07-17 23:07","pubTimestamp":1721228849,"startTime":"0","endTime":"0","summary":"北京时间2024年07月17日23时07分，Pliant Therapeutics, Inc.股票出现异动，股价急速跳水5.04%。Pliant Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为2.56%。Pliant Therapeutics, Inc.公司简介：Pliant Therapeutics Inc 是一家临床阶段的生物制药公司，专注于发现和开发治疗纤维化和相关疾病的新疗法。消息层面，截至23时07分，《富国集团维持Pliant Therapeutics买入评级，维持目标价41美元》资讯为影响Pliant Therapeutics, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717230729941f7f0f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717230729941f7f0f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PLRX","BK4139","LENZ"],"gpt_icon":0},{"id":"2451262846","title":"Pliant Therapeutics, Inc.盘中异动 早盘股价大涨5.15%报13.41美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2451262846","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451262846?lang=zh_cn&edition=full","pubTime":"2024-07-15 21:46","pubTimestamp":1721051207,"startTime":"0","endTime":"0","summary":"北京时间2024年07月15日21时46分，Pliant Therapeutics, Inc.股票出现异动，股价大幅上涨5.15%。截至发稿，该股报13.41美元/股，成交量6.0658万股，换手率0.10%，振幅4.08%。Pliant Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.52%。Pliant Therapeutics, Inc.公司简介：Pliant Therapeutics Inc 是一家临床阶段的生物制药公司，专注于发现和开发治疗纤维化和相关疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240715214648af926563&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240715214648af926563&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PLRX","BK4007","BK4139","LENZ"],"gpt_icon":0},{"id":"2435351292","title":"BUZZ-Pliant Therapeutics公司肺病药物在中期研究中获得成功，业绩上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2435351292","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435351292?lang=zh_cn&edition=full","pubTime":"2024-05-14 22:46","pubTimestamp":1715697967,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    5月14日 - ** Pliant Therapeutics   股价上涨1.7%至13.90美元** 该公司的实验性特发性肺纤维化(IPF) 药物在中期研究中显示，与患者肺部疾病进展有关的蛋白质减少了 (link) ** 这种名为bexotegrast的药物还能改善咳嗽的严重程度** IPF是肺纤维化中最常见的一种类型，这种疾病会导致肺部结疤** 公司称数据显示瘢痕有可能逆转** 年初至今股价下跌 22.6","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BUZZ","LENZ","BK4007","PLRX"],"gpt_icon":0},{"id":"2435515073","title":"Pliant Therapeutics, Inc.盘中异动 早盘大幅拉升5.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2435515073","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435515073?lang=zh_cn&edition=full","pubTime":"2024-05-14 21:31","pubTimestamp":1715693494,"startTime":"0","endTime":"0","summary":"北京时间2024年05月14日21时31分，Pliant Therapeutics, Inc.股票出现波动，股价大幅拉升5.45%。Pliant Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.04%。其相关个股中，Nutriband Inc C/Wts 、Generation Bio Co.、Taysha Gene Therapies, Inc.涨幅较大，Allarity Therapeutics, Inc.、Transcode Therapeutics, Inc.、Enveric Biosciences, Inc.较为活跃，换手率分别为35.03%、7.26%、6.50%，振幅较大的相关个股有Transcode Therapeutics, Inc.、Allogene Therapeutics, Inc.、Taysha Gene Therapies, Inc.，振幅分别为21.54%、12.41%、11.67%。Pliant Therapeutics, Inc.公司简介：Pliant Therapeutics Inc 是一家临床阶段的生物制药公司，专注于发现和开发治疗纤维化和相关疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405142131347a59d86b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405142131347a59d86b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","BK4139","PLRX"],"gpt_icon":0},{"id":"2434772077","title":"Pliant Therapeutics, Inc.盘中异动 急速下挫5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2434772077","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434772077?lang=zh_cn&edition=full","pubTime":"2024-05-09 02:26","pubTimestamp":1715192777,"startTime":"0","endTime":"0","summary":"北京时间2024年05月09日02时26分，Pliant Therapeutics, Inc.股票出现波动，股价快速下挫5.11%。Pliant Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.41%。Pliant Therapeutics, Inc.公司简介：Pliant Therapeutics Inc 是一家临床阶段的生物制药公司，专注于发现和开发治疗纤维化和相关疾病的新疗法。该信息摘要如下：花旗：维持Pliant Therapeutics评级，由买入调整至买入评级, 目标价由45.00美元调整至44.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240509022617861ebd6b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240509022617861ebd6b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PLRX","LENZ","BK4139","BK4007"],"gpt_icon":0},{"id":"2433733217","title":"花旗：维持Pliant Therapeutics(PLRX.US)评级，由买入调整至买入评级, 目标价由45.00美元调整至44.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2433733217","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433733217?lang=zh_cn&edition=full","pubTime":"2024-05-08 01:45","pubTimestamp":1715103938,"startTime":"0","endTime":"0","summary":"花旗：维持Pliant Therapeutics(PLRX.US)评级，由买入调整至买入评级, 目标价由45.00美元调整至44.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050801454187dd3672&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050801454187dd3672&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PLRX","LENZ"],"gpt_icon":0},{"id":"2433273144","title":"HC Wainwright & Co.：重申Pliant Therapeutics(PLRX.US)评级，由买入调整至买入评级, 目标价36.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2433273144","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433273144?lang=zh_cn&edition=full","pubTime":"2024-05-07 18:25","pubTimestamp":1715077528,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.：重申Pliant Therapeutics(PLRX.US)评级，由买入调整至买入评级, 目标价36.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405071825328ae4a97c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405071825328ae4a97c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","PLRX"],"gpt_icon":0},{"id":"2432504975","title":"Pliant Therapeutics Inc    预计每股亏损 77 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2432504975","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432504975?lang=zh_cn&edition=full","pubTime":"2024-05-03 19:53","pubTimestamp":1714737190,"startTime":"0","endTime":"0","summary":"   * Pliant Therapeutics Inc    预计将在5月7日公布截至2024年3月31日的季度业绩(估计)，季度收入将出现下降。* 根据LSEG的数据，10位分析师的平均预期显示，这家总部位于加利福尼亚州旧金山南部的公司的营收预计将从去年同期的133万美元下降65.1%，至46.45万美元。* LSEG 分析师对 Pliant Therapeutics Inc 的平均预期是每股亏损 77 美分。* 华尔街对 Pliant Therapeutics Inc 的 12 个月目标价中位数为 43.00 美元，高于其上次收盘价 13.25 美元。5月3日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","PLRX"],"gpt_icon":0},{"id":"2426349419","title":"Pliant Therapeutics, Inc.盘中异动 快速跳水5.43%报14.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426349419","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2426349419?lang=zh_cn&edition=full","pubTime":"2024-04-10 21:40","pubTimestamp":1712756449,"startTime":"0","endTime":"0","summary":"北京时间2024年04月10日21时40分，Pliant Therapeutics, Inc.股票出现波动，股价大幅下跌5.43%。Pliant Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.45%。其相关个股中，Adial Pharmaceuticals, Inc、Tc Biopharm  Plc C/Wts 10/02/2028 、Calidi Biotherapeutics, Inc.涨幅较大，Adial Pharmaceuticals, Inc、Silo Pharma, Inc.、Abvc Biopharma, Inc.较为活跃，换手率分别为1186.85%、69.63%、26.26%，振幅较大的相关个股有Adial Pharmaceuticals, Inc、Calidi Biotherapeutics, Inc.、Silo Pharma, Inc.，振幅分别为51.33%、31.96%、24.26%。Pliant Therapeutics, Inc.公司简介：Pliant Therapeutics Inc 是一家临床阶段的生物制药公司，专注于发现和开发治疗纤维化和相关疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240410214049791fac46&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240410214049791fac46&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","PLRX","LENZ"],"gpt_icon":0},{"id":"2419982197","title":"Pliant Therapeutics, Inc.盘中异动 急速下跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2419982197","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2419982197?lang=zh_cn&edition=full","pubTime":"2024-03-15 00:26","pubTimestamp":1710433575,"startTime":"0","endTime":"0","summary":"北京时间2024年03月15日00时26分，Pliant Therapeutics, Inc.股票出现波动，股价快速下挫5.01%。Pliant Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.31%。其相关个股中，Revolution Medicines Inc C/Wts 17/12/2026 、Psyence Biomedical Ltd.、知临集团涨幅较大，知临集团、Novabay Pharmaceuticals, Inc.、Psyence Biomedical Ltd.较为活跃，换手率分别为757.79%、174.82%、91.75%，振幅较大的相关个股有Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Psyence Biomedical Ltd.、知临集团，振幅分别为110.40%、80.77%、76.91%。Pliant Therapeutics, Inc.公司简介：Pliant Therapeutics Inc 是一家临床阶段的生物制药公司，专注于发现和开发治疗纤维化和相关疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403150026157a4cbd52&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403150026157a4cbd52&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PLRX","BK4007"],"gpt_icon":0},{"id":"2418553160","title":"Pliant Therapeutics, Inc.盘中异动 早盘股价大涨5.16%报15.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2418553160","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2418553160?lang=zh_cn&edition=full","pubTime":"2024-03-12 22:07","pubTimestamp":1710252447,"startTime":"0","endTime":"0","summary":"北京时间2024年03月12日22时07分，Pliant Therapeutics, Inc.股票出现异动，股价急速拉升5.16%。截至发稿，该股报15.28美元/股，成交量18.7223万股，换手率0.31%，振幅6.16%。Pliant Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.47%。Pliant Therapeutics, Inc.公司简介：Pliant Therapeutics Inc 是一家临床阶段的生物制药公司，专注于发现和开发治疗纤维化和相关疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403122207287919bd53&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403122207287919bd53&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PLRX","BK4007"],"gpt_icon":0},{"id":"2416348640","title":"Pliant Therapeutics, Inc.盘中异动 早盘股价大涨5.10%报16.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2416348640","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2416348640?lang=zh_cn&edition=full","pubTime":"2024-03-01 23:50","pubTimestamp":1709308257,"startTime":"0","endTime":"0","summary":"北京时间2024年03月01日23时50分，Pliant Therapeutics, Inc.股票出现波动，股价大幅拉升5.10%。Pliant Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为2.36%。其相关个股中，Biovie Inc.、Adial Pharmaceuticals, Inc、Carmell Corp C/Wts 12/07/2028 涨幅较大，Adial Pharmaceuticals, Inc、Enveric Biosciences, Inc.、Jaguar Health, Inc.较为活跃，换手率分别为3541.05%、378.65%、267.57%，振幅较大的相关个股有Pasithea Therapeutics Corp C/Wts 12/08/2026 、Jaguar Health, Inc.、Biovie Inc.，振幅分别为81.48%、81.19%、76.61%。Pliant Therapeutics, Inc.公司简介：Pliant Therapeutics Inc 是一家临床阶段的生物制药公司，专注于发现和开发治疗纤维化和相关疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403012350587916620e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403012350587916620e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PLRX","BK4007"],"gpt_icon":0},{"id":"2415371490","title":"Pliant Therapeutics Inc盘中异动 急速下挫5.17%报16.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2415371490","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2415371490?lang=zh_cn&edition=full","pubTime":"2024-02-29 00:14","pubTimestamp":1709136850,"startTime":"0","endTime":"0","summary":"北京时间2024年02月29日00时14分，Pliant Therapeutics Inc股票出现波动，股价大幅下跌5.17%。Pliant Therapeutics Inc股票所在的生物技术行业中，整体跌幅为0.49%。其相关个股中，Vivani Medical Inc、Adial Pharmaceuticals Inc、Vtv Therapeutics Inc涨幅较大，Adial Pharmaceuticals Inc、Vivani Medical Inc、Zyversa Therapeutics Inc较为活跃，换手率分别为4252.33%、189.47%、80.14%，振幅较大的相关个股有Vivani Medical Inc、Adial Pharmaceuticals Inc、Ys Biopharma Co Ltd C/Wts 15/03/2028 ，振幅分别为382.18%、219.84%、93.93%。Pliant Therapeutics Inc公司简介：Pliant Therapeutics Inc 是一家临床阶段的生物制药公司，专注于发现和开发治疗纤维化和相关疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022900141079159100&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022900141079159100&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PLRX"],"gpt_icon":0},{"id":"2411365916","title":"Pliant Therapeutics Inc盘中异动 早盘快速跳水5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2411365916","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2411365916?lang=zh_cn&edition=full","pubTime":"2024-02-13 22:49","pubTimestamp":1707835758,"startTime":"0","endTime":"0","summary":"北京时间2024年02月13日22时49分，Pliant Therapeutics Inc股票出现异动，股价快速跳水5.04%。Pliant Therapeutics Inc股票所在的生物技术行业中，整体跌幅为0.75%。其相关个股中，Cingulate Inc C/Wts 10/12/2026 、Larimar Therapeutics Inc、Protagenic Therapeutics Inc涨幅较大，Biodexa Pharmaceuticals Plc、Adial Pharmaceuticals Inc、Kintara Therapeutics Inc较为活跃，换手率分别为324.28%、100.06%、58.30%，振幅较大的相关个股有Cingulate Inc C/Wts 10/12/2026 、Larimar Therapeutics Inc、Adial Pharmaceuticals Inc，振幅分别为46.15%、36.37%、36.24%。Pliant Therapeutics Inc公司简介：Pliant Therapeutics Inc 是一家临床阶段的生物制药公司，专注于发现和开发治疗纤维化和相关疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024021322491879113c89&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024021322491879113c89&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PLRX","BK4007"],"gpt_icon":0},{"id":"2409482444","title":"美国研究综述-空气化工产品公司 , Hubspot 和麦当劳","url":"https://stock-news.laohu8.com/highlight/detail?id=2409482444","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2409482444?lang=zh_cn&edition=full","pubTime":"2024-02-06 15:31","pubTimestamp":1707204662,"startTime":"0","endTime":"0","summary":"    路透2月6日 - 华尔街证券分析师周二调整了对几家美国上市公司的评级和目标价，其中包括空气化工产品公司、Hubspot 和麦当劳。要闻             * 空气化工产品公司  ：摩根大通将目标价从295美元下调至270美元              * Hubspot Inc   ：杰富瑞将目标价从620美元上调至695美元              * 麦当劳   ：BTIG将其目标价从 \"买入 \"下调至 \"中性\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BURL","SUN","CTLT","APPN","HUBS","AVPT","LU2237443382.USD","PCTY","AMKR","BK4101","LU2264538146.SGD","LU2362541513.USD","MCD","ON","CAH","SIGI","THG","GE","KO","VRTX","TSN","LU0310799852.SGD","LU2362541273.HKD","KGS","BK4512","RMBS","QTWO","TRGP","PAYC","EL","SG9999011175.SGD","GEL","PYCR","RMNI","ROST","APD","BK4209","PLTR","EW","SSD","CAT","KVYO","VRNS","BK4113","TGT","COR","LPG","BK4114","PLRX","GO"],"gpt_icon":0},{"id":"2409438474","title":"Pliant Therapeutics Inc盘中异动 大幅下跌6.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2409438474","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2409438474?lang=zh_cn&edition=full","pubTime":"2024-02-05 22:30","pubTimestamp":1707143454,"startTime":"0","endTime":"0","summary":"北京时间2024年02月05日22时30分，Pliant Therapeutics Inc股票出现波动，股价急速下挫6.55%。Pliant Therapeutics Inc股票所在的生物技术行业中，整体跌幅为1.56%。其相关个股中，4D Molecular Therapeutics Inc、Genprex Inc、180 Life Sciences Corp C/Wts 07/11/2025涨幅较大，Biorestorative Therapies Inc、Revelation Biosciences Inc、Clearmind Medicine Inc较为活跃，换手率分别为115.44%、40.43%、34.65%，振幅较大的相关个股有180 Life Sciences Corp C/Wts 07/11/2025、Oragenics Inc、Cel-Sci Corp，振幅分别为31.58%、6.36%、4.08%。Pliant Therapeutics Inc公司简介：Pliant Therapeutics Inc 是一家临床阶段的生物制药公司，专注于发现和开发治疗纤维化和相关疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240205223054861d223b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240205223054861d223b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PLRX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://pliantrx.com","stockEarnings":[{"period":"1week","weight":0.1596},{"period":"1month","weight":0.1482},{"period":"3month","weight":0.055},{"period":"6month","weight":-0.2299},{"period":"1year","weight":-0.2867},{"period":"ytd","weight":-0.2899}],"compareEarnings":[{"period":"1week","weight":-0.0078},{"period":"1month","weight":0.018},{"period":"3month","weight":0.115},{"period":"6month","weight":0.1544},{"period":"1year","weight":0.2262},{"period":"ytd","weight":0.1717}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Pliant Therapeutics, Inc. 于2015年6月根据特拉华州法律注册成立。该公司是一家临床阶段生物制药公司，致力于发现和开发用于治疗纤维化的新疗法。 他们最初的重点是通过抑制整合素介导的TGF-β活化来治疗纤维化。 该公司利用他们对纤维化生物学的深刻理解，以及他们在药物化学和转化医学方面的专业知识，开发了一套专有工具，旨在快速有效地发现和降低候选产品的风险。 他们的全资主要候选药物PLN-74809是整合素的口服小分子双重选择性抑制剂，该公司正在开发该药物用于治疗特发性肺纤维化或IPF，原发性硬化性胆管炎或PSC。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.188578},{"month":2,"riseRate":0.25,"avgChangeRate":-0.023967},{"month":3,"riseRate":0.25,"avgChangeRate":-0.064037},{"month":4,"riseRate":0.25,"avgChangeRate":-0.114241},{"month":5,"riseRate":0.25,"avgChangeRate":-0.087511},{"month":6,"riseRate":0.25,"avgChangeRate":0.028855},{"month":7,"riseRate":0.4,"avgChangeRate":0.152109},{"month":8,"riseRate":0.5,"avgChangeRate":0.009745},{"month":9,"riseRate":0.5,"avgChangeRate":-0.015802},{"month":10,"riseRate":0.25,"avgChangeRate":-0.016303},{"month":11,"riseRate":0.25,"avgChangeRate":-0.037772},{"month":12,"riseRate":0.5,"avgChangeRate":0.033282}],"exchange":"NASDAQ","name":"Pliant Therapeutics, Inc.","nameEN":"Pliant Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Pliant Therapeutics, Inc.(PLRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Pliant Therapeutics, Inc.(PLRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Pliant Therapeutics, Inc.,PLRX,Pliant Therapeutics, Inc.股票,Pliant Therapeutics, Inc.股票老虎,Pliant Therapeutics, Inc.股票老虎国际,Pliant Therapeutics, Inc.行情,Pliant Therapeutics, Inc.股票行情,Pliant Therapeutics, Inc.股价,Pliant Therapeutics, Inc.股市,Pliant Therapeutics, Inc.股票价格,Pliant Therapeutics, Inc.股票交易,Pliant Therapeutics, Inc.股票购买,Pliant Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Pliant Therapeutics, Inc.(PLRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Pliant Therapeutics, Inc.(PLRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}